ISMPP Highlights
ISMPP-Sponsored Study on PLS Now Published in CMRO Presents Expert Perspectives
A new paper from the ISMPP PLS Perspectives Working Group has been published in Current Medical Research & Opinion. The paper presents findings from an ISMPP-sponsored, evidence-based study reporting on expert stakeholder perspectives to inform best practices for plain language summaries (PLS)…
ISMPP to be Featured in Advancements Television Series in 1Q 2022
ISMPP is honored to be featured in an upcoming episode of Advancements with Ted Danson, scheduled for broadcast in 1Q 2022. The Advancements television segment will present information about the medical publications profession and ISMPP’s role in establishing and maintaining standards for the profession…
Beyond Words: How Voice, Graphics, and Video are Changing the Way Researchers Reach Audiences
A new resource, Article Enhancements: A Beginners Guide, from the ISMPP Social Media and Web-based Metrics Working Group, seeks to inform, educate, and answer questions about many of the ways authors are now able to present data and their findings to readers…
Message from Our Leadership
Robert J. Matheis
ISMPP President and CEO
News and Trends
THE FUTURE OF ADVISORY BOARDS – Is This the End of the In-Person Format?
When writing The MAP article, “Advisory Boards: Words of Advice and a 10-point Checklist”, released in March 2020, we could not have predicted the era of unprecedented change that was to come. Many pharmaceutical companies had already been reaping the benefits of fully virtual advisory boards pre-COVID-19, but the necessity to move all meetings to a fully online format required a significant shift in strategy and mindset…
The Public Face of Science: Elevating Trust through Medical Communications – Continuing the Conversation
In any relationship, whether business or personal, transparency breeds trust. Today, despite the life science industry delivering unprecedented vaccine solutions to address the Covid pandemic, mistrust remains engrained in the public persona. Third parties have leveraged that doubt for their own gain…
A Snapshot into Medical Affairs
What does a Medical Affairs team look like at a pharmaceutical/biotechnology company? Is it like a bag of M&M’S® with similar functions, or is it unique from company to company, like a fingerprint? We conducted a survey of ISMPP members in March 2021, that provides insights into what comprises Medical Affairs at pharmaceutical/biotechnology companies…
What Would You Do?
In our role as medical publication professionals, we may occasionally encounter situations in which it is not obvious how to ensure good publication practice. Have you ever wished you could consult the ISMPP membership for guidance when these situations arise? Here’s your opportunity!
What Would You Do? is a section of The MAP that presents case scenarios as an educational tool for medical publication professionals. The section provides a case scenario to ponder, and readers are invited to participate in a poll by selecting one of the listed solutions. Readers can also submit their thoughts on the scenario anonymously. The poll results, plus educational insights, are posted in a later issue for readers to digest.
Preprint Review Results in Added Author?
You are the Scientific Director of a medical communications agency who is working with the Publications Director at a large pharma company. An external author posts draft one of a preclinical manuscript on their department preprint server to invite review and comments from colleagues who performed some of the work yet did not meet all ICMJE criteria for full authorship…
ISMPP (pronounced IzMap) is the only nonprofit organization founded by medical publication professionals for medical publication professionals